Dr. Melinda Cail from Primary Health Partners joins us in the KFOR Studios on Thursday afternoon to discuss Parkinson's disease.

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and ...

Long-term cycling programs appear to reshape brain signals in Parkinson’s patients Deep brain stimulation recordings reveal ...

Major institutional investors have increased their exposure to neurological disorder treatment companies in 2024 and 2025, ...

Rosemary has long been linked to memory. In Shakespeare’s Hamlet, the character Ophelia says, “There’s rosemary, that’s for ...